Raloxifene Hydrochloride

Preferred Label : Raloxifene Hydrochloride;

MeSH definition : A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.;

MeSH synonym : keoxifene hydrochloride; Raloxifene HCl;

CISMeF synonym : 82640-04-8 (Raloxifene hydrochloride); ELi lilly brand of raloxifene; lilly brand of raloxifene; raloxifene lilly brand;

MeSH Hyperonym : raloxifene; Keoxifene;

MeSH hyponym : evista; LY-156758; LY-139481; LY139481; LY 139481; LY156758; LY 156758;

MeSH CAS label : methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-;

MeSH Related Number : raloxifene hydrochloride; 82640-04-8 (HCl); 84449-90-1 (Raloxifene); 82640-04-8 (raloxifene hydrochloride); 84449-90-1; YX9162EO3I;

Registry Number MeSH : 84449-90-1;

Related CAS MeSH : 4F86W47BR6 (Raloxifene hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Raloxifene;

Is substance : O;

UNII : YX9162EO3I; 4F86W47BR6;

InChIKey : GZUITABIAKMVPG-UHFFFAOYSA-N;

Details

Origin ID

D020849;

UMLS CUI

C0618111;

ATC code(s)
- raloxifene [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- raloxifene hydrochloride [Substance BNPC]
Pharmacological action(s)
- bone density conservation agents [MeSH Descriptor]
- estrogen antagonists [MeSH Descriptor]
- selective estrogen receptor modulators [MeSH Descriptor]
Record concept(s)
- LY-139481 [MeSH concept]
- LY-156758 [MeSH concept]
- evista [MeSH concept]
- raloxifene [MeSH concept]
- raloxifene hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- Y134 compound [MeSH Supplementary Concept]
- iodoraloxifene [MeSH Supplementary Concept]
- raloxifene diphosphate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Raloxifene Hydrochloride [NCIt concept]
- Raloxifene Hydrochloride [International Nonproprietary Name]
- Raloxifene hydrochloride (substance) [SNOMED CT concept]
- raloxifene hydrochloride [Substance BNPC]
Validated automatic mappings to BTNT
- raloxifene [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients